Ingredient record · Steroid, often in skin creams
Betamethasone: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
14 entries containing Betamethasone are on India's banned-drugs list, and 7 are banned today. 29 batches of medicines containing Betamethasone failed a government lab test between June 2019 and July 2026, from 19 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
7
Banned combinations in force
7
Other listed orders (stayed, restricted, quashed)
29
Batches failed a lab test
Jul 2026
Latest lab alert
On the banned-drugs list
Betamethasone on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Chloramphenicol + Lignocaine + Betamethasone + Clotrimazole + Ofloxacin + AntipyrineFixed-dose combination · skin | Banned | S.O. 4490(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Ofloxacin + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Banned | S.O. 4491(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Gentamicin Sulphate + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Banned | S.O. 4492(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Betamethasone + Fusidic Acid + Gentamicin + Tolnaftate + Iodochlorhydroxyquinoline (ICHQ)Fixed-dose combination · skin | Banned | S.O. 4656(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Betamethasone + Gentamicin + Tolnaftate + IodochlorhydroxyquinolineFixed-dose combination · skin | Banned | S.O. 4665(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Betamethasone + Neomycin + Tolnaftate + Iodochlorhydroxyquinoline + ChlorocresolFixed-dose combination · skin | Banned | S.O. 4669(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Betamethasone + Gentamicin + Zinc Sulphate + Clotrimazole + ChlorocresolFixed-dose combination · skin | Banned | S.O. 4675(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Chloramphenicol + Lignocaine + Betamethasone + Clotrimazole + Ofloxacin + AntipyrineFixed-dose combination · skin | Quashed | S.O. 827(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Ofloxacin + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Quashed | S.O. 828(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Gentamicin Sulphate + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Quashed | S.O. 829(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Betamethasone + Fusidicacid + Gentamicin + Tolnaftate + Iodochlorhydroxyquinoline(ichq)Fixed-dose combination · skin | Quashed | S.O. 1002(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Betamethasone + Gentamicin + Tolnaftate + IodochlorhydroxyquinolineFixed-dose combination · skin | Quashed | S.O. 1011(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Betamethasone + Neomycin + Tolnaftate + Iodochlorohydroxyquinoline + CholorocresolFixed-dose combination · skin | Quashed | S.O. 1015(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Betamethasone + Gentamicin + Zinc Sulphate + Clotrimazole + ChlorocresolFixed-dose combination · skin | Quashed | S.O. 1021(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Betamethasone Sodium Phosphate | 10 | 10 | Jul 2026 |
| Betamethasone Valerate | 4 | 2 | Jul 2026 |
| Betamethasone Valerate W/w | 4 | 1 | Jun 2025 |
| Betamethasone Valerate Neomycin Skin | 3 | 2 | Jul 2026 |
| Betamethasone Clioquinol | 2 | 1 | Dec 2022 |
| Betamethasone Clindamycin Nicotinamide | 1 | 1 | Jul 2026 |
| Betamethasone Valerate Salicylic Acid | 1 | 1 | Jul 2026 |
| Deco | 1 | 1 | Jul 2025 |
| Betamethasone Sodium Phosphate /ml | 1 | 1 | Dec 2023 |
| Betamethasone Dipropionate | 1 | 1 | Oct 2019 |
| M Betasone | 1 | 1 | Jun 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Betamethasone, Clindamycin & Nicotinamide Cream | 1391Mfg 2026-02 · Exp 2028-01 | Lucrose Pharma Pvt. Ltd. Flat No. 197Uttar Pradesh | Content of Betamethasone & ClindamycinOther | GORAKHPUR LAB, UPState lab | Jul 2026 |
| Betamethasone valerate & Salicylic Acid Ointment | BE533Mfg 2025-06 · Exp 2027-05 | Bestcare Formulation PvtPuducherry | Content (Nil)Other | Drug testing laboratory, Chennai-6State lab | Jul 2026 |
| Betamethasone Valerate Ointment IP | RF695Mfg 2025-06 · Exp 2027-05 | Curetech SkincareHimachal Pradesh | Content of Betamethasone (73.7%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Betamethasone Sodium Phosphate Injection I.P. | HL11006MMfg 2025-12 · Exp 2027-11 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conforms to the IP with respect to Description, Particulate Matter and Assay.Assay | DTL JaipurState lab | Jul 2026 |
| BETAMETHASONE VALERATE AND NEOMYCIN SKIN CREAM | YW6KMfg 2026-02 · Exp 2027-07 | GlaxoSmithKline Pharmaceuticals LimitedMaharashtra | The Sample does not conform to claim with respect to the Assay of Neomycin Sulphate.Assay | DTL, DelhiState lab | Jul 2026 |
| Betamethasone Valerate Ointment IP | RH896Mfg 2025-08 · Exp 2027-07 | Curetech SkincareHimachal Pradesh | ContentOther | DTL, Madurai-19State lab | Feb 2026 |
| Betamethasone Valerate Ointment IP | RF653Mfg 2025-06 · Exp 2027-05 | Curetech SkincareHimachal Pradesh | ContentOther | DTL, Chennai-06State lab | Feb 2026 |
| Betamethasone Sodium Phosphate Tablets IP | 501303Mfg 2025-02 · Exp 2027-01 | Comed Chemicals LimitedGujarat | DescriptionDescription | State Drugs Laboratory, PunjabState lab | Aug 2025 |
| Deco (Chloramphenicol & Betamethasone Sodium Sodium Phosphate eye/ear Drops) | NDCO-019Mfg 2023-10 · Exp 2025-09 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The Sample dose not conforms to claim as per Patent & Proprietary in respect to assay of Chloramphenicol.Assay | Drug Testing Laboratory Baddi, Himanchal PradeshState lab | Jul 2025 |
| Betamethasone sodium Phosphate Tablets IP (Betop) | GTD1505Mfg 2025-04 · Exp 2027-03 | Gidsha PharmaceuticalsGujarat | The sample does not conform to th IP with respect to Assay of Vitamin D3Assay | DTL, JaipurState lab | Jul 2025 |
| Betamethasone Sodium Phosphate Tablets I.P. 0.5 mg(Medibetal) | OS-241004Mfg 2024-10 · Exp 2026-09 | Ossiske Life Science Pvt Ltd. F-18 | The sample does not conform to the IP with respect to Assay of Betamethasone sodium Phosphate eq to BetamethasoneAssay | DTL, JaipurState lab | Jul 2025 |
| Betamethasone Valerate Ointment IP 0.1% w/w | B82Mfg 2024-08 · Exp 2026-07 | Syndicate PharmaMadhya Pradesh | Content of Betamethasone in Betamethasone ValerateOther | CDTL ChennaiCDSCO lab | Jun 2025 |
| Betamethasone Valerate Ointment IP 0.1% w/w | B73Mfg 2024-08 · Exp 2026-07 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Betamethasone Sodium Phosphate Injection IP (Betagin 1 ml) | P24L107Mfg 2024-08 · Exp 2026-07 | Paksons Pharmaceuticals Private LimitedHaryana | Particulate matter, Assay of Betamethasone Sodium Phosphate and DescriptionAssay | CDL, KolkataCDSCO lab | May 2025 |
| Betamethasone Valerate Ointment IP 0.1% w/w | B75Mfg 2024-08 · Exp 2026-07 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | DTL MaduraiState lab | Apr 2025 |
Showing 15 of 29 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.